Posted On: 06/09/2016 7:55:07 AM
Post# of 99388
$OREX Pr Candle. $0.64
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave® Patent LitigationPR Newswire(Wed, Jun
Shares Outstanding: 145.57M
Float: 101.50M
% Held by Insiders: 34.03%
% Held by Institutions: 88.10%
Shares Short (as of May 13, 20163: 22.52M
Short Ratio (as of May 13, 2016): 8.51
Short % of Float (as of May 13, 2016): 21.30%
Shares Short (prior month): 23.13M
Headlines
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products. The company offers Contrave for the treatment of obesity. It has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave in the United States, Canada, and Mexico. The companys product, Contrave also approved under the brand name of Mysimba in Europe. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave® Patent LitigationPR Newswire(Wed, Jun
Shares Outstanding: 145.57M
Float: 101.50M
% Held by Insiders: 34.03%
% Held by Institutions: 88.10%
Shares Short (as of May 13, 20163: 22.52M
Short Ratio (as of May 13, 2016): 8.51
Short % of Float (as of May 13, 2016): 21.30%
Shares Short (prior month): 23.13M
Headlines
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products. The company offers Contrave for the treatment of obesity. It has a collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize Contrave in the United States, Canada, and Mexico. The companys product, Contrave also approved under the brand name of Mysimba in Europe. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California.
(0)
(0)
